Clinical Research & Trials
Explore the phases of clinical trials and how patients can participate in groundbreaking cancer research.
Phase I
This phase is focused on testing the safety of a new drug in human beings and determining the best route of administration. Approximately 20 to 30 patients are enrolled for this phase.
Phase II
In this phase, researchers test whether the new drug works for a specific type of cancer while monitoring for adverse events. Fewer than 100 patients are typically enrolled.
Phase III
Involving hundreds to thousands of patients, Phase III compares the new drug with standard treatment. Patients are divided into controlled and study groups, often using randomization to ensure unbiased results.
Phase IV
After FDA approval, Phase IV studies continue to monitor the long-term effects and safety of the new drug in a broader patient population.
How to Enroll in a Clinical Trial?
Each clinical trial has strict eligibility criteria for participation. If you're interested in enrolling, your doctor will discuss the trial with you, covering the drug's safety, treatment protocols, and the potential risks and benefits involved. After this discussion, if you choose to participate, you'll sign a consent form, and a copy will be provided for your records.
Benefits
- Early access to new treatments.
- Participation in potentially groundbreaking research.
- Some medical tests and treatments may be covered by the trial sponsor.
Risks
- Unexpected side effects.
- New treatment may not be as effective as standard care.
- Risk of severe adverse reactions.